{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T20:49:47Z","timestamp":1648846187018},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2010,4,28]],"date-time":"2010-04-28T00:00:00Z","timestamp":1272412800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ophthalmologe"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1007\/s00347-009-2108-9","type":"journal-article","created":{"date-parts":[[2010,5,7]],"date-time":"2010-05-07T09:24:44Z","timestamp":1273224284000},"page":"621-627","source":"Crossref","is-referenced-by-count":1,"title":["Neuronale Zeroidlipofuszinosen (NCL) im Tiermodell"],"prefix":"10.1007","volume":"107","author":[{"given":"K.","family":"R\u00fcther","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,4,28]]},"reference":[{"key":"2108_CR1","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.ymgme.2005.11.005","volume":"87","author":"Awano","year":"2006","unstructured":"Awano T, Katz ML, O\u2019Brien DP et al (2006a) A mutation in the cathepsin D gene (CTSD) in American bulldogs with neuronal ceroid lipofuscinosis. Mol Genet Metab 87:341\u2013348","journal-title":"Mol Genet Metab"},{"key":"2108_CR2","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.ymgme.2006.02.016","volume":"89","author":"Awano","year":"2006","unstructured":"Awano T, Katz ML, O\u2019Brien DP et al (2006b) A frame shift mutation in canine TPP1 (the ortholog of human CLN2) in a juvenile Dachshund with neuronal ceroid lipofuscinosis. Mol Genet Metab 89:254\u2013260","journal-title":"Mol Genet Metab"},{"key":"2108_CR3","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1046\/j.1460-9568.2002.02299.x","volume":"16","author":"Bertamini","year":"2002","unstructured":"Bertamini M, Marzani B, Guarneri R et al (2002) Mitochondrial oxidative metabolism in motor neuron degeneration (mnd) mouse central nervous system. Eur J Neurosci 16:2291\u20132296","journal-title":"Eur J Neurosci"},{"key":"2108_CR4","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/1097-4547(20001015)62:2<234::AID-JNR8>3.0.CO;2-8","volume":"62","author":"Cho","year":"2000","unstructured":"Cho S, Dawson PE, Dawson (2000) Antisense palmitoyl protein thioesterase 1 (PPT1) treatment inhibits PPT1 activity and increases cell death in LA-N-5 neuroblastoma cells. J Neurosci Res 62:234\u2013234","journal-title":"J Neurosci Res"},{"key":"2108_CR5","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1093\/hmg\/11.22.2709","volume":"11","author":"Cotman","year":"2002","unstructured":"Cotman SL, Vrbanac V, Lebel LA et al (2002) Cln3(Deltaex7\/8) knock-in mice with the common JNCL mutation exhibit progressive neurologic disease that begins before birth. Hum Mol Genet 11:2709\u20132721","journal-title":"Hum Mol Genet"},{"key":"2108_CR6","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1172\/JCI3112","volume":"102","author":"Das","year":"1998","unstructured":"Das AK, Becerra CH, Yi W et al (1998) Molecular genetics of palmitoyl-protein thioesterase deficiency in the U.S. J Clin Invest 102:361\u2013370","journal-title":"J Clin Invest"},{"key":"2108_CR7","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1007\/s10545-005-0125-7","volume":"28","author":"Voer","year":"2005","unstructured":"Voer G de, Bent P van der, Rodrigues AJ et al (2005) Deletion of the caenorhabditis elegans homologues of the CLN3 gene, involved in human juvenile neuronal ceroid lipofuscinosis, causes a mild progeric phenotype. J Inherit Metab Dis 28:1065\u20131080","journal-title":"J Inherit Metab Dis"},{"key":"2108_CR8","doi-asserted-by":"crossref","first-page":"9826","DOI":"10.1523\/JNEUROSCI.1710-07.2007","volume":"27","author":"Eliason","year":"2007","unstructured":"Eliason SL, Stein CS, Mao Q et al (2007) A knock-in reporter model of Batten disease. J Neurosci 27:9826\u20139834","journal-title":"J Neurosci"},{"key":"2108_CR9","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0014-5793(03)00162-5","volume":"538","author":"Elshatory","year":"2003","unstructured":"Elshatory Y, Brooks AI, Chattopadhyay S (2003) Early changes in gene expression in two models of Batten disease. FEBS Lett 538:207\u2013212","journal-title":"FEBS Lett"},{"key":"2108_CR10","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.nbd.2007.09.006","volume":"29","author":"Frugier","year":"2008","unstructured":"Frugier T, Mitchell NL, Tammen I et al (2008) A new large animal model of CLN5 neuronal ceroid lipofuscinosis in Borderdale sheep is caused by a nucleotide substitution at a consensus splice site (c.571+1G>A) leading to excision of exon 3. Neurobiol Dis 29:306\u2013315","journal-title":"Neurobiol Dis"},{"key":"2108_CR11","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.ymthe.2005.04.018","volume":"12","author":"Griffey","year":"2005","unstructured":"Griffey M, Macauley SL, Ogilvie JM, Sands MS (2005) AAV2-mediated ocular gene therapy for infantile neuronal ceroid lipofuscinosis. Mol Ther 12:413\u2013421","journal-title":"Mol Ther"},{"key":"2108_CR12","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.ymthe.2005.11.008","volume":"13","author":"Griffey","year":"2006","unstructured":"Griffey MA, Wozniak D, Wong M et al (2006) CNS-directed AAV2-mediated gene therapy ameliorates functional deficits in a murine model of infantile neuronal ceroid lipofuscinosis. Mol Ther 13:538\u2013547","journal-title":"Mol Ther"},{"key":"2108_CR13","doi-asserted-by":"crossref","first-page":"13566","DOI":"10.1073\/pnas.251485198","volume":"98","author":"Gupta","year":"2001","unstructured":"Gupta P, Soyombo AA, Atashband A et al (2001) Disruption of PPT1 or PPT2 causes neuronal ceroid lipofuscinosis in knockout mice. Proc Natl Acad Sci U S A 98:13566\u2013135671","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2108_CR14","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.bbadis.2006.07.008","volume":"1762","author":"Houweling","year":"2006","unstructured":"Houweling PJ, Cavanagh JA, Palmer DN et al (2006) Neuronal ceroid lipofuscinosis in Devon cattle is caused by a single base duplication (c.662dupG) in the bovine CLN5 gene. Biochim Biophys Acta 1762:890\u2013897","journal-title":"Biochim Biophys Acta"},{"key":"2108_CR15","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.nbd.2004.08.013","volume":"18","author":"Jalanko","year":"2005","unstructured":"Jalanko A, Vesa J, Manninen T et al (2005) Mice with Ppt1Deltaex4 mutation replicate the INCL phenotype and show an inflammation-associated loss of interneurons. Neurobiol Dis 18:226\u2013241","journal-title":"Neurobiol Dis"},{"key":"2108_CR16","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.bbamcr.2008.11.004","volume":"1793","author":"J","year":"2009","unstructured":"J Jalanko A, Braulke T (2009) Neuronal ceroid lipofuscinoses. Biochim Biophys Acta 1793:697\u2013709","journal-title":"Biochim Biophys Acta"},{"key":"2108_CR17","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1365-2990.1989.tb01236.x","volume":"15","author":"Jolly","year":"1989","unstructured":"Jolly RD, Shimada A, Dopfmer I et al (1989) Ceroid-lipofuscinosis (Batten\u2019s disease): pathogenesis and sequential neuropathological changes in the ovine model. Neuropathol Appl Neurobiol 15:371\u2013383","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2108_CR18","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/(SICI)1097-4547(19990815)57:4<551::AID-JNR15>3.0.CO;2-R","volume":"57","author":"Katz","year":"1999","unstructured":"Katz ML, Shibuya H, Liu PC et al (1999) A mouse gene knockout model for juvenile ceroid-lipofuscinosis (Batten disease). J Neurosci Res 57:551\u2013556","journal-title":"J Neurosci Res"},{"key":"2108_CR19","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.bbrc.2004.12.038","volume":"327","author":"Katz","year":"2005","unstructured":"Katz ML, Khan S, Awano T et al (2005) A mutation in the CLN8 gene in English Setter dogs with neuronal ceroid-lipofuscinosis. Biochem Biophys Res Commun 327:541\u2013547","journal-title":"Biochem Biophys Res Commun"},{"key":"2108_CR20","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/j.1750-3639.2006.00002.x","volume":"16","author":"Kay","year":"2006","unstructured":"Kay GW, Palmer DN, Rezaie P, Cooper JD (2006) Activation of non-neuronal cells within the prenatal developing brain of sheep with neuronal ceroid lipofuscinosis. Brain Pathol 16:110\u2013116","journal-title":"Brain Pathol"},{"key":"2108_CR21","doi-asserted-by":"crossref","first-page":"6898","DOI":"10.1523\/JNEUROSCI.20-18-06898.2000","volume":"20","author":"Koike","year":"2000","unstructured":"Koike M, Nakanishi H, Saftig P et al (2000) Cathepsin D deficiency induces lysosomal storage with ceroid lipofuscin in mouse CNS neurons. J Neurosci 20:6898\u20136906","journal-title":"J Neurosci"},{"key":"2108_CR22","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/S1044-7431(03)00035-6","volume":"22","author":"Koike","year":"2003","unstructured":"Koike M, Shibata M, Ohsawa Y et al (2003) Involvement of two different cell death pathways in retinal atrophy of cathepsin D-deficient mice. Mol Cell Neurosci 22:146\u2013161","journal-title":"Mol Cell Neurosci"},{"key":"2108_CR23","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1093\/hmg\/ddh312","volume":"13","author":"Kopra","year":"2004","unstructured":"Kopra O, Vesa J, Schantz C von et al (2004) A mouse model for Finnish variant late infantile neuronal ceroid lipofuscinosis, CLN5, reveals neuropathology associated with early aging. Hum Mol Genet 13:2893\u20132906","journal-title":"Hum Mol Genet"},{"key":"2108_CR24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0404.1997.tb00059.x","volume":"95","author":"Lang","year":"1997","unstructured":"Lang AH, Hirvasniemi A, Siivola J (1997) Neurophysiological findings in the northern epilepsy syndrome. Acta Neurol Scand 95:1\u20138","journal-title":"Acta Neurol Scand"},{"key":"2108_CR25","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1093\/hmg\/10.19.2123","volume":"10","author":"Luiro","year":"2001","unstructured":"Luiro K, Kopra O, Lehtovirta M, Jalanko A (2001) CLN3 protein is targeted to neuronal synapses but excluded from synaptic vesicles: new clues to Batten disease. Hum Mol Genet 10:2123\u20132131","journal-title":"Hum Mol Genet"},{"key":"2108_CR26","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ygeno.2005.06.005","volume":"86","author":"Melville","year":"2005","unstructured":"Melville SA, Wilson CL, Chiang CS et al (2005) A mutation in canine CLN5 causes neuronal ceroid lipofuscinosis in border collie dogs. Genomics 86:287\u2013294","journal-title":"Genomics"},{"key":"2108_CR27","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/ajmg.1320570251","volume":"57","author":"Messer","year":"1995","unstructured":"Messer A, Plummer J, MacMillen MC, Frankel WN (1995) Genetics of primary and timing effects in the mnd mouse. Am J Med Genet 57:361\u2013364","journal-title":"Am J Med Genet"},{"key":"2108_CR28","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1006\/nbdi.2000.0281","volume":"7","author":"Mitchison","year":"1999","unstructured":"Mitchison HM, Bernard DJ, Greene ND et al (1999) Targeted disruption of the Cln3 gene provides a mouse model for Batten disease. The Batten mouse model consortium. Neurobiol Dis 6:321\u2013334. Erratum in. Neurobiol Dis 2000 7(2):127","journal-title":"Neurobiol Dis 2000"},{"key":"2108_CR29","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/nen.0b013e31815f3899","volume":"67","author":"Partanen","year":"2008","unstructured":"Partanen S, Haapanen A, Kielar C et al (2008) Synaptic changes in the thalamocortical system of cathepsin D-deficient mice: a model of human congenital neuronal ceroid-lipofuscinosis. J Neuropathol Exp Neurol 67:16\u201329","journal-title":"J Neuropathol Exp Neurol"},{"key":"2108_CR30","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1523\/JNEUROSCI.2676-05.2006","volume":"26","author":"Passini","year":"2006","unstructured":"Passini MA, Dodge JC, Bu J et al (2006) Intracranial delivery of CLN2 reduces brain pathology in a mouse model of classical late infantile neuronal ceroid lipofuscinosis. J Neurosci 26:1334\u20131342","journal-title":"J Neurosci"},{"key":"2108_CR31","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/13868","volume":"23","author":"Ranta","year":"1999","unstructured":"Ranta S, Zhang Y, Ross B et al (1999) The neuronal ceroid lipofuscinoses in human EPMR and mnd mutant mice are associated with mutations in CLN8. Nat Genet 23:233\u2013236","journal-title":"Nat Genet"},{"key":"2108_CR32","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1002\/j.1460-2075.1995.tb00029.x","volume":"14","author":"Saftig","year":"1995","unstructured":"Saftig P, Hetman M, Schmahl W et al (1995) Mice deficient for the lysosomal proteinase cathepsin D exhibit progressive atrophy of the intestinal mucosa and profound destruction of lymphoid cells. EMBO J 14:3599\u20133608","journal-title":"EMBO J"},{"key":"2108_CR33","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.nbd.2009.02.001","volume":"34","author":"Schantz","year":"2009","unstructured":"Schantz C, Kielar C, Hansen SN et al (2009) Progressive thalamocortical neuron loss in Cln5 deficient mice: Distinct effects in Finnish variant late infantile NCL. Neurobiol Dis 34:308\u2013319","journal-title":"Neurobiol Dis"},{"key":"2108_CR34","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1074\/jbc.M509483200","volume":"281","author":"Schulz","year":"2006","unstructured":"Schulz A, Mousallem T, Venkataramani M et al (2006) The CLN9 protein, a regulator of dihydroceramide synthase. J Biol Chem 281:2784\u20132794","journal-title":"J Biol Chem"},{"key":"2108_CR35","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1006\/mcne.2001.1099","volume":"19","author":"Seigel","year":"2002","unstructured":"Seigel GM, Lotery A, Kummer A et al (2002) Retinal pathology and function in a Cln3 knockout mouse model of juvenile neuronal ceroid Lipofuscinosis (Batten disease). Mol Cell Neurosci 19:515\u2013527","journal-title":"Mol Cell Neurosci"},{"key":"2108_CR36","doi-asserted-by":"crossref","unstructured":"Seigel GM, Wagner J, Wronska A et al (2005) Progression of early postnatal retinal pathology in a mouse model of neuronal ceroid lipofuscinosis. Eye (Lond) 19:1306\u20131312","DOI":"10.1038\/sj.eye.6701770"},{"key":"2108_CR37","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1093\/brain\/awl107","volume":"129","author":"Siintola","year":"2006","unstructured":"Siintola E, Partanen S, Str\u00f6mme P et al (2006) Cathepsin D deficiency underlies congenital human neuronal ceroid-lipofuscinosis. Brain 129:1438\u20131445","journal-title":"Brain"},{"key":"2108_CR38","doi-asserted-by":"crossref","first-page":"9117","DOI":"10.1523\/JNEUROSCI.2729-04.2004","volume":"24","author":"Sleat","year":"2004","unstructured":"Sleat DE, Wiseman JA, El-Banna M et al (2004) A mouse model of classical late-infantile neuronal ceroid lipofuscinosis based on targeted disruption of the CLN2 gene results in a loss of tripeptidyl-peptidase I activity and progressive neurodegeneration. J Neurosci 24:9117\u20139126","journal-title":"J Neurosci"},{"key":"2108_CR39","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/sj.mt.6300049","volume":"15","author":"Sondhi","year":"2007","unstructured":"Sondhi D, Hackett NR, Peterson DA et al (2007) Enhanced survival of the LINCL mouse following CLN2 gene transfer using the rh.10 rhesus macaque-derived adeno-associated virus vector. Mol Ther 15:481\u2013491","journal-title":"Mol Ther"},{"key":"2108_CR40","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1086\/504159","volume":"78","author":"Steinfeld","year":"2006","unstructured":"Steinfeld R, Reinhardt K, Schreiber K et al (2006) Cathepsin D deficiency is associated with a human neurodegenerative disorder. Am J Hum Genet 78:988\u2013998","journal-title":"Am J Hum Genet"},{"key":"2108_CR41","doi-asserted-by":"crossref","first-page":"2786","DOI":"10.1093\/emboj\/19.12.2786","volume":"19","author":"Tyynel\u00e4","year":"2000","unstructured":"Tyynel\u00e4 J, Sohar I, Sleat DE et al (2000) A mutation in the ovine cathepsin D gene causes a congenital lysosomal storage disease with profound neurodegeneration. EMBO J 19:2786\u20132792","journal-title":"EMBO J"},{"key":"2108_CR42","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.nbd.2005.11.008","volume":"22","author":"Weimer","year":"2006","unstructured":"Weimer JM, Custer AW, Benedict JW et al (2006) Visual deficits in a mouse model of Batten disease are the result of optic nerve degeneration and loss of dorsal lateral geniculate thalamic neurons. Neurobiol Dis 22:284\u2013293","journal-title":"Neurobiol Dis"},{"key":"2108_CR43","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1086\/338708","volume":"70","author":"Wheeler","year":"2002","unstructured":"Wheeler RB, Sharp JD, Schultz RA et al (2002) The gene mutated in variant late-infantile neuronal ceroid lipofuscinosis (CLN6) and in nclf mutant mice encodes a novel predicted transmembrane protein. Am J Hum Genet 70:537\u2013542","journal-title":"Am J Hum Genet"},{"key":"2108_CR44","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1089\/hum.2008.022","volume":"19","author":"Worgall","year":"2008","unstructured":"Worgall S, Sondhi D, Hackett NR et al (2008) Treatment of late infantile neuronal ceroid lipofuscinosis by CNS administration of a serotype 2 adeno-associated virus expressing CLN2 cDNA. Hum Gene Ther 19:463\u2013474","journal-title":"Hum Gene Ther"},{"key":"2108_CR45","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.pediatrneurol.2007.01.008","volume":"36","author":"Zelnik","year":"2007","unstructured":"Zelnik N, Mahajna M, Iancu TC et al (2007) A novel mutation of the CLN8 gene: is there a mediterranean phenotype? Pediatr Neurol 36:411\u2013413","journal-title":"Pediatr Neurol"}],"container-title":["Der Ophthalmologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-009-2108-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00347-009-2108-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-009-2108-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,4]],"date-time":"2020-06-04T11:29:00Z","timestamp":1591270140000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00347-009-2108-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4,28]]},"references-count":45,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["2108"],"URL":"https:\/\/doi.org\/10.1007\/s00347-009-2108-9","relation":{},"ISSN":["0941-293X","1433-0423"],"issn-type":[{"value":"0941-293X","type":"print"},{"value":"1433-0423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,4,28]]}}}